The U.S. Food and Drug Administration approved the first over-the-counter birth control pill, broadening access to buy birth control pills without a prescription.
As per the study authors, use of hormonal birth control pills is associated with a relative 20 to 30 per cent increased risk of breast cancer. TheHealthSite.com
Share:
Pune, India, Jan. 22, 2021 (GLOBE NEWSWIRE) The
global Biopharmaceutical CMO Market is projected to showcase an impressive growth owing to the increasing need to outsource the manufacturing process in the biopharmaceutical industry, observes Fortune Business Insights™ in an upcoming report, these organizations allow pharmaceutical companies to outsource some aspects of their business, which saves their valuable time and aids them to focus on the development of drugs.
While making the report, we segmented the market on the basis of product, type, consumption, distribution channel, and region. Based on the segmentation, we made a list of companies and conducted a detailed analysis of their financial positions, product portfolios, and growth strategies. Our next step included the study of core competencies of key players and their market share to anticipate the degree of competition. The bottom-up procedure was conducted to arrive at the overall size of the market.